Wall Street RegretsThe regret calculator.

What if you'd held SABS?

A $1,000 investment in SAB Biotherapeutics, Inc. (SABS) at the month-end close of 2021-02 would be worth $37.50 at the close of 2026-08 — -96.3% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $2,022.

$1,000 since 2021$37.50Total return-96.3%Multiple0.04×CAGR-45.0%

Your scenario

Dates resolve to the nearest month-end close.
Leave empty for "held until today".
Invested at each month-end. Starts on the buy date.

Result

Worth$37.50Gain+$-963 (-96.3%)Multiple0.0×CAGR-45.0%

    If you'd bought $1,000 at the start of each year

    Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.

    2021$37.502022$48.402023$6412024$5492025$9972026$1,011

    Every year, $1,000 from 2021

    YearValue of $1,000Year return
    2021$1,000
    2022$75.54-92.4%
    2023$88.09+16.6%
    2024$48.53-44.9%
    2025$47.89-1.3%
    2026$48.40+1.1%

    Best and worst month-end to buy

    The best single month-end close to have bought SABS was 2025-03 ($1.36): $1,000 then is $2,779 today. The worst was 2021-11 ($109): $1,000 then is $34.71.

    FAQ

    What would $1,000 in SABS be worth today?

    A $1,000 investment in SAB Biotherapeutics, Inc. (SABS) at the start of 2021 would be worth about $37.50 today, a total return of -96.3%. Dividends are reinvested in these figures.

    What were the best and worst years for SABS?

    SAB Biotherapeutics, Inc. (SABS)'s strongest calendar year since 2021 was 2023, a +16.6% return — $1,000 held through that year became about $1,166 by year-end. Its weakest year was 2022, at -92.4%.

    Does the calculator include dividends and splits?

    Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.

    How much would $100 per month in SABS have grown?

    Investing $100 at the end of every month since 2021-02 would have grown to about $5,343 on $6,700 invested.

    Did SABS beat the S&P 500?

    Over the same period, $1,000 in the S&P 500 index would be worth $2,022. SABS trailed the S&P 500 by +98.1% in total return.

    Is this investment advice?

    No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.

    Methodology

    SAB Biotherapeutics, Inc. (SABS) historical total-return data from 2021-02 to 2026-08, reduced to month-end closes for the tables above.

    Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.

    Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.

    Full methodology →

    What if you'd held…

    Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.